ELI LILLY AND COMPANY

ELI LILLY AND COMPANY
World Rank (Sep-01-2021)
40
Market Cap (Sep-01-2021)
247.070 Billion USD
World Rank (Jan-01-2021)
69
Market Value (Jan-01-2021)
161.510 Billion USD
World Rank (Jan-2020)
82
Market Value (Jan 1st 2020)
128.184 Billion USD
World Rank (July-04-2020)
58
Market Cap (July-04-2020):
156.733 Billion USD
World Rank (Aug-22-2020):
71
Market Cap (Aug-22-2020)
142.763 Billion USD
Annual Revenue in USD
24,530 Million USD
Annual Results for Year Ending
Dec-2020
Annual Net Income in USD
6,190 Million USD
Stock Category
S&P 500
Headquarters Region
Indiana
Headquarters Country
USA
Headquarters Continent
Americas
World Sub Region
Northern America
Rank in Country (Jan-2020)
Rank in USA in 2020 is 48
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 43
Company Business
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Technology
Number of Employees
33,815
Employee Count as on Date
As on 2019
CEO:
David A. Ricks
Founders
Eli Lilly
Founded Year
1876
Stock Exchange
NYSE
Bovespa Brazil
Switzerland
EURONEXT
Yahoo @ NYSE
Wikipedia
Twitter
Facebook
Bloomberg
Company Website:
Eli Lilly And Company - Pharmaceutical Company
Business Sector:
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
Annual Revenue
ELI LILLY AND COMPANY Annual Revenues for December-2020 ending is 24.53 Billion USD
Annual Operating Income
6.85 Billion USD for Year ending December-2020
Annual Net Income
ELI LILLY AND COMPANY Annual Net Income for December-2020 ending is 6.19 Billion USD
Total Current Assets
ELI LILLY AND COMPANY Total Current Assets as on June-2020 is 14,581 Million USD
Total Assets
ELI LILLY AND COMPANY Total Assets as on June-2020 is 41,967 Million USD
Total Current Liabilities
ELI LILLY AND COMPANY Total Current Liabilities as on June-2020 is 11,988 Million USD
Total Liabilities
ELI LILLY AND COMPANY Total Liabilities as on June-2020 is 37,695 Million USD
Total Equity
ELI LILLY AND COMPANY Total Equity as on June-2020 is 4,093 Million USD
About Company Business:

Eli Lilly is a healthcare and pharmaceutical and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Eli Lilly has 33,815 employees as on 2019. Headquarters is in USA.

Annual Results Summary:

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Year - Ending Revenue Net Profit EPS (USD)
Dec-2020 24,539 6,193  
Dec-2019 22,319 8,318 8.69
Dec-2018 24,555 3,232 3.14
Dec-2017 22,871 -204  (Loss) -0.19
Dec-2016 21,222 2,737 2.49
Balance Sheet Summary

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Year Ending: Total Current Assets Total Assets Total Current Liabilities Total Liabilities Total Equity
Dec-2020 17,462 46,633 12,481 40,807 5,641
Dec-2019 13,710 39,286 11,775 36,587 2,607
Dec-2018 20,550 43,908 11,888 32,999 9,829
Dec-2017 19,202 44,981 14,536 33,313 11,592
Dec-2016 15,101 38,806 10,987 24,725 14,008
Quarterly Results Summary:

Eli Lilly and Company - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending Revenue Net Profit EPS (USD)
Sep-2021 6,772 1,110 1.16
Jun-2021 6,740 1,390 1.39
Mar-2021 6,805 1,355 1.35
Dec-2020 7,440 2,116 2.11
Sep-2020 4,414 1,208 1.54
Jun-2020 4,277 1,412 1.89
Mar-2020 5,859 1,456 1.52
Dec-2019 6,114 1,495 1.56
Sep-2019 5,476 1,253 1.31
Jun-2019 5,636 1,327 1.53
Mar-2019 5,092 4,241 4.31
Dec-2018 6,438 1,125 1.10
Sep-2018 6,061 1,149 1.11

Share it on Social Media